Management of Atrial Fibrillation With Flecainide : the AFFLEC Study
NCT02190175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-09-07
Summary
This is a multicentre non interventional observational study with the objective to follow up patients with atrial fibrillation who based on current indications are treated with per os flecainide , for cardiac pulse maintenance.
Conditions
Sponsors & Collaborators
-
Hellenic Cardiovascular Research Society
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-11-30
- Completion
- 2015-12-31
Countries
- Greece
Study Locations
More Related Trials
-
Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice
NCT05617456 ·Status: RECRUITING
-
To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation
NCT00189319 ·Status: COMPLETED ·Phase: PHASE4
-
The Influence of Genetic Predisposition on Outcome After Catheter Ablation of Atrial Fibrillation.
NCT04753541 ·Status: UNKNOWN
-
Blood Pressure Assessment in Atrial Fibrillation
NCT01088269 ·Status: UNKNOWN
-
BLITZ Atrial Fibrillation
NCT03653598 ·Status: COMPLETED
-
Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation
NCT02614521 ·Status: WITHDRAWN
-
Acute Atrial Fibrillation and Flutter Treated Electively
NCT04267159 ·Status: RECRUITING ·Phase: NA
-
LOSE-AF: Can Weight Loss Help Patients With Atrial Fibrillation?
NCT03713775 ·Status: COMPLETED ·Phase: NA
-
cliNIcal sCEnarios and Pathophysiology of Atrial Fibrillation
NCT04320134 ·Status: UNKNOWN
-
Flecainide-Short Long Study (Flec-SL)
NCT00215774 ·Status: COMPLETED ·Phase: NA
-
AcQForce Pulsed Field Ablation-CE
NCT05113056 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation in Relationship to Plasma Biomarkers
NCT04710745 ·Status: UNKNOWN
-
Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.
NCT00035451 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Adipokines In Atrial Fibrillation
NCT03592732 ·Status: UNKNOWN
-
AIHEMAF - P "An Innovative Healthcare Model for AF Patients"
NCT05086991 ·Status: COMPLETED
-
Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
NCT03656523 ·Status: COMPLETED
-
Atrial Fibrillation Characterization on Paroxysmal and Persistent Patients
NCT05343923 ·Status: COMPLETED
-
Atherosclerosis in Atrial Fibrillation
NCT01882114 ·Status: UNKNOWN
-
Pulsed-field Ablation Vs. Sham Ablation to Treat AF
NCT05717725 ·Status: RECRUITING ·Phase: PHASE3
-
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
NCT00000556 ·Status: COMPLETED ·Phase: PHASE3
-
Calcium Handling and Epicardial Ablation
NCT04174885 ·Status: COMPLETED ·Phase: NA
-
Persistent Atrial Fibrillation Ablation Trial
NCT01891825 ·Status: SUSPENDED ·Phase: NA
-
CArdioversion of Short Duration Atrial Fibrillation
NCT02112318 ·Status: TERMINATED
-
Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study)
NCT03303872 ·Status: UNKNOWN
-
Atrial Flutter Ablation in a Real World Population
NCT02591875 ·Status: UNKNOWN